China

Title
‘Creatogether’: Givaudan Collaborates with TMIC to Launch Fragrance Industry’s First AI-powered Fragrance Co-creation Service in China
“Creatogether”: Givaudan kooperiert mit TMIC, um den branchenweit ersten KI-basierten Co-Creation-Service für Riechstoffe in China zu lancieren.
Azelis receives 2023 Ringier Technology Innovation Award for Personal Care
Azelis Strengthens its Position in the Chinese Personal Care Market with the Acquisition of CosBond
BASF Announces an Innovation Partnership with Start-up Ingredi, China, including a Strategic Equity Investment
BASF: Innovationspartnerschaft einschließlich strategischer Kapitalbeteiligung mit dem chinesischen Start-up-Unternehmen Ingredi
Clariant Announces New Investments to Enhance Chinese Ethoxylation Plant
CP Kelco Reports Extensive Progress in Expansion of Biogums Production Capacity at U.S., China Facilities
Givaudan eröffnet neuen Digital Space, einen digitalen Raum, um Innovationen voranzutreiben und das Wachstum des Unternehmens gemeinsam mit seinen Kunden in China fortzusetzen
Givaudan Leads Fine Fragrance Digital Innovation through First-of-its-kind Partnership with Tmall in China
Givaudan Opens new Digital Space to Drive Innovation and Continue Growing with its Customers in China
Givaudan übernimmt die Führung bei der digitalen Innovation in der Luxusparfümerie durch die erste Partnerschaft ihrer Art mit Tmall in China
Nouryon Awarded Responsible Care® Merit Award in China
PCHi 2023 Concludes with Record Attendance in Guangzhou
Sabinsa Nanjing Expands into New Facility in Nanjing, China
SGS China Opens a New Facility in Xiamen for Cosmetics Testing
SGS Opens a New Cosmetics Testing Facility in Hangzhou, China to meet Growing Demand
sofw journal 10-2005
sofw journal 11-2004
sofw journal 11-2004
Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.